Filtered By:
Specialty: Rheumatology
Source: Journal of Rheumatology
Condition: Arthritis
This page shows you your search results in order of date. This is page number 3.
Order by Relevance | Date
Total 47 results found since Jan 2013.
Epidemiology and survival of systemic sclerosis-sarcoidosis overlap syndrome
CONCLUSION: Sarcoidosis in SSc is rare but appears to occur more frequently than the general population. It is associated with pulmonary, lymph node, cutaneous, joint and hepatic involvement. Stroke occurs more frequently in SSc-sarcoidosis patients but with no differences in survival.PMID:36725057 | DOI:10.3899/jrheum.220877
Source: Journal of Rheumatology - February 1, 2023 Category: Rheumatology Authors: Megan Himmel Meyer Balter Zareen Ahmad Elvira Bangert Shafina Hasmani Rhea Siddha Mohammad Movahedi Sindhu R Johnson Source Type: research
Risk Factors for Dementia in Patients with Incident Rheumatoid Arthritis: A Population-based Cohort Study
CONCLUSION: Apart from age, hypertension, depression, and anxiety, which are universally recognized risk factors for dementia, clinically active RA and presence of CVD were associated with an elevated risk of dementia incidence among RA patients.PMID:35840149 | DOI:10.3899/jrheum.220200
Source: Journal of Rheumatology - July 15, 2022 Category: Rheumatology Authors: Chanakya Kodishala Cassondra A Hulshizer Vanessa L Kronzer John M Davis Vijay K Ramanan Maria Vassilaki Michelle M Mielke Cynthia S Crowson Elena Myasoedova Source Type: research
Improved Incidence of Cardiovascular Disease in Patients with Incident Rheumatoid Arthritis in the 2000s: a Population-Based Cohort Study.
CONCLUSION: Incidence of major CVD events in RA has declined in recent decades. The gap in CVD occurrence between RA patients and the general population is closing. Mortality after CVD events in RA may be improving.
PMID: 33589553 [PubMed - as supplied by publisher]
Source: Journal of Rheumatology - February 17, 2021 Category: Rheumatology Tags: J Rheumatol Source Type: research
The risk of cardiovascular events associated with disease-modifying antirheumatic drugs in rheumatoid arthritis.
CONCLUSION: Abatacept and TNFi were associated with decreased risk of CVD compared to csDMARDs. Minimizing glucocorticoid use and optimizing MTX dose may improve CV outcomes in patients with RA.
PMID: 32801134 [PubMed - as supplied by publisher]
Source: Journal of Rheumatology - August 18, 2020 Category: Rheumatology Tags: J Rheumatol Source Type: research
